期刊文献+

评价终末期肝病肝脏储备功能的进展 被引量:3

The Progress of Evaluating the Liver Store Function of the End-stage Liver Disease
暂未订购
导出
摘要 准确评价终末期肝病患者的肝脏储备功能有利于临床医生为患者选择个体化的治疗方案,特别是近年来肝移植技术的发展迫切需要一个精确、简便和客观的标准。肝功能分级(Child-Turcotte-Pugh,CTP)分级用于临床已有40多年了,在判断终末期肝病的肝脏储备功能上越来越显示其局限性。终末期肝功病模型(Model for End-stage Liver Disease,MELD)是近年来创立的判断终末期肝病患者的肝脏储备功能的新方法,其在临床应用尤其在肝移植方面已显示出许多优越性。该文主要对CTP分级和MELD评分的产生、特点、临床应用及存在的问题作一综述。 To evaluate the liver store function of patients with liver disease in teminal stage is helpful for doctors to select individualized therapeutic regimen for the patients, especially in recent years, an precise, simple and objective criteria is needed urgently with the development of liver transplantation. Although the CTP has been used for more than 40 years, its limitation is becoming more and more obvious in liver store function judgement of liver disease in its teminal stage. The Model for End-stage Liver Disease(MELD)is a new method to evaluate the liver store function of the end-stage liver disease in recent years. It has showed much more advantages in clinical practice, especially in liver transplantation. This article reviews CTP and MELD about their designs, characters, clinical applications and existing problems respectively.
出处 《医学综述》 2006年第17期1075-1077,共3页 Medical Recapitulate
关键词 终末期肝病 CTP分级 MELD评分 The endstage liver disease The classification of Child-Turcotte-Pugb The grade of Model for End-stage Liver Disease
  • 相关文献

参考文献1

二级参考文献26

  • 1Cooper GS,Bellamy P,Dawson NV,Desbiens N,Fulkerson WJ,Goldman L, Quin LM,Speroff T,Landefeld CS.A prognostic model for patients with end-stage liver disease.Gastroenterology 1997;113:1278-1288.
  • 2Wiesner RH,McDiarmid SV,Kamath PS,Edwards EB,Malinchoc M,Kremers WK, Krom RA,Kim WR.MELD and PELD:application of survival models to liver allocation.Liver Transvl 2001:7:567-580.
  • 3Mccaughan GW,Strasser SI.To MELD or not to MELD?Hepatology 2001; 34:215-216.
  • 4Kamath PS,Wiesner RH,Malinchoc M,Kremers W,Therneau TM,Kosberg CL, D'Amico G,Dickson ER,Kim WR.A modelto predict survival in patients with endstage liver disease.Hepatology 2001;33:464-470.
  • 5Malinchoc M,Kamath PS,Gordon FD,Peine CJ,Rank J,ter Borg PCJ.A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.Hetmtology 2000,31:864-871.
  • 6Angermayr B,Koenig F,Cejna M,Karnel F,Gschwantler M,Ferenci P,Gangl A,Peck-Radosavljevic M.Creatinine-modities Child-Pugh score (CPSC) compared with MELD-score to predict survival in patients undergoing TIPS.Hepatology 2002;36:378A.
  • 7Angermayr B,Cejna M,Karnel F,Gschwantler M,Koenig F,Pidlich J, Mendel H,Pichler L,Wichlas M,Kreil A,Schmid M,Ferlitsch A,Lipinski E,Brunner H,Lammer J,Ferenci P,Gangl A,Peck-Radosavljevic M. Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portystemic shunt.Gut 2003,52:879-885.
  • 8Moreau R,Lebrec D.Acute renal failure in patients with cirrhosis: perspectives in the age of MELD.Hepatology 2003;37:233-243.
  • 9Nair S,Verma S,Thuluvath PJ.Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 2002:35:1179-1185.
  • 10DeLong ER,DeLong DM,Clarke-Pearson DL.Comparing the areas under two or more correlated receiving operating characteristics curves:a nonparametric approach.Biometrics 1988;44:837-845.

共引文献32

同被引文献17

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部